Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Benner

Showing results (421-430 of 470) with videos related to

Pageof 47
Sort By:
Applied and Environmental Microbiology|October 25, 2011
Experimental evolution of a facultative thermophile from a mesophilic ancestorIan K Blaby, Benjamin J Lyons, Ewa Wroclawska-Hughes, et al.
British Journal of Cancer|December 3, 2013
Tumour-site-dependent expression profile of angiogenic factors in tumour-associated stroma of primary colorectal cancer and metastasesC Kahlert, M Pecqueux, N Halama, et al.
Nature Communications|October 26, 2023
Enzymatic synthesis and nanopore sequencing of 12-letter supernumerary DNAHinako Kawabe, Christopher A Thomas, Shuichi Hoshika, et al.
Nature Communications|August 6, 2025
Sequencing a DNA analog composed of artificial basesChristopher A Thomas, Henry Brinkerhoff, Jonathan M Craig, et al.
Leukemia|May 5, 2015
The regulatory interaction of EVI1 with the TCL1A oncogene impacts cell survival and clinical outcome in CLLE Vasyutina, J M Boucas, J Bloehdorn, et al.
Blood Cancer Journal|July 30, 2016
Pretransplant NPM1 MRD levels predict outcome after allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemiaS Kayser, A Benner, C Thiede, et al.
Annals of Hematology|July 8, 2003
Joint HOVON-50/GMMG-HD3 randomized trial on the effect of thalidomide as part of a high-dose therapy regimen and as maintenance treatment for newly diagnosed myeloma patientsH Goldschmidt, P Sonneveld, F W Cremer, et al.
Bone Marrow Transplantation|July 2, 2013
Risk factors and containment of respiratory syncytial virus outbreak in a hematology and transplant unitN Lehners, P Schnitzler, S Geis, et al.
The Pharmacogenomics Journal|March 18, 2015
Genetic variants in DNA repair genes as potential predictive markers for oxaliplatin chemotherapy in colorectal cancerE J Kap, P Seibold, S Richter, et al.
Leukemia|July 30, 2003
Risk-adapted postremission therapy in acute myeloid leukemia: results of the German multicenter AML HD93 treatment trialR F Schlenk, A Benner, F Hartmann, et al.
Pageof 47

Showing results (421-430 of 470) with videos related to

Sort By:
Pageof 47
Applied and Environmental Microbiology|October 25, 2011
Experimental evolution of a facultative thermophile from a mesophilic ancestorIan K Blaby, Benjamin J Lyons, Ewa Wroclawska-Hughes, et al.
British Journal of Cancer|December 3, 2013
Tumour-site-dependent expression profile of angiogenic factors in tumour-associated stroma of primary colorectal cancer and metastasesC Kahlert, M Pecqueux, N Halama, et al.
Nature Communications|October 26, 2023
Enzymatic synthesis and nanopore sequencing of 12-letter supernumerary DNAHinako Kawabe, Christopher A Thomas, Shuichi Hoshika, et al.
Nature Communications|August 6, 2025
Sequencing a DNA analog composed of artificial basesChristopher A Thomas, Henry Brinkerhoff, Jonathan M Craig, et al.
Leukemia|May 5, 2015
The regulatory interaction of EVI1 with the TCL1A oncogene impacts cell survival and clinical outcome in CLLE Vasyutina, J M Boucas, J Bloehdorn, et al.
Blood Cancer Journal|July 30, 2016
Pretransplant NPM1 MRD levels predict outcome after allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemiaS Kayser, A Benner, C Thiede, et al.
Annals of Hematology|July 8, 2003
Joint HOVON-50/GMMG-HD3 randomized trial on the effect of thalidomide as part of a high-dose therapy regimen and as maintenance treatment for newly diagnosed myeloma patientsH Goldschmidt, P Sonneveld, F W Cremer, et al.
Bone Marrow Transplantation|July 2, 2013
Risk factors and containment of respiratory syncytial virus outbreak in a hematology and transplant unitN Lehners, P Schnitzler, S Geis, et al.
The Pharmacogenomics Journal|March 18, 2015
Genetic variants in DNA repair genes as potential predictive markers for oxaliplatin chemotherapy in colorectal cancerE J Kap, P Seibold, S Richter, et al.
Leukemia|July 30, 2003
Risk-adapted postremission therapy in acute myeloid leukemia: results of the German multicenter AML HD93 treatment trialR F Schlenk, A Benner, F Hartmann, et al.
Pageof 47